Specifically, Ye et al. found claudin-3 levels to be associated with distant metastasis in cancer cells, preoperative PSA levels, tumor diameter, and the pathological stage of the disease (Ye et al., 2019). This evidence concerns the gene CLDN3 and neoplasm.